A Phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies

بواسطة Collier, Katharine A., Valencia, Hugo, Newton, Herbert, Hade, Erinn M., Sborov, Douglas W., Cavaliere, Robert, Poi, Ming, Phelps, Mitch A., Liva, Sophia G., Coss, Christopher C., Wang, Jiang, Khountham, Soun, Monk, Paul, Shapiro, Charles L., Piekarz, Richard, Hofmeister, Craig C., Bradley Welling, D., Mortazavi, Amir
الحاوية / القاعدة Cancer Chemother Pharmacol (2021)

Open access: Is there a predator at the door?

بواسطة Chandra, Rakesh, Fisher, Edward W., Jones, Terry M., Kennedy, David W., Kraus, Dennis H., Krouse, John H., Link, Michael, Lustig, Lawrence R., O'Malley, Bert W., Piccirillo, Jay F., Ruben, Robert, Sataloff, Robert T., Sindwani, Raj, Smith, Richard J., Stewart, Michael G., Weber, Peter C., Bradley Welling, D., Youngs, Robin
الحاوية / القاعدة Laryngoscope Investig Otolaryngol (2018)